VR-PMR for Post-Burn Symptoms
VIBE
Virtual Reality-Enhanced Progressive Muscle Relaxation for Symptom Management in Burn Survivors
1 other identifier
interventional
34
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether progressive muscle relaxation (PMR), delivered either alone or enhanced with virtual reality (VR), can help treat chronic symptom, such as pain, itch, anxiety, sleep disturbances, and fatigue, in adult burn survivors. The main questions it aims to answer are:
- Does VR-enhanced PMR (VR-PMR) reduce chronic pain, anxiety, itch, sleep disturbances, and fatigue more effectively than standard PMR?
- Is VR-PMR a feasible and acceptable self-administered home-based intervention for burn survivors? Researchers will compare two self-administered intervention conditions, VR-enhanced PMR and standard PMR, using a randomized to sequence crossover design to see if VR technology enhances the therapeutic effects of PMR on chronic symptom management in burn survivors. Participants will:
- Complete home-based sessions of VR-enhanced PMR
- Complete home-based sessions of standard PMR
- Report symptoms such as pain, itch, anxiety, sleep disturbances, and fatigue throughout the study
- Use VR equipment provided for the intervention period (during the VR-PMR arm)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2025
CompletedFirst Posted
Study publicly available on registry
January 5, 2026
CompletedStudy Start
First participant enrolled
February 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
March 5, 2026
March 1, 2026
9 months
December 10, 2025
March 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pain Intensity as assessed by the the Numeric Rating Scale (NRS).
Pain will be measured using the the Numeric Rating Scale (NRS). Scale range 0-10, higher score worse pain severity.
pre intervention and post VR-PMR intervention (3 weeks)
Itch Intensity as assessed by the the Numeric Rating Scale (NRS)
Itch intensity pre- and post-intervention will be measured using the the Numeric Rating Scale (NRS). Scale range 0-10, higher score worse itch severity.
pre intervention and post VR-PMR intervention (3 weeks)
Anxiety as assessed by the Numeric Rating Scale
Anxiety severity pre- and post-intervention will be measured using the Numeric Rating Scale. Total score range from 0-10 with higher scores indicating worse anxiety.
Pre intervention, post VR-PMR intervention (3 weeks)
Secondary Outcomes (7)
Quality of Life (Burn Specific Health Scale Brief)
pre intervention and post intervention (3 weeks)
Sleep Disturbances as assessed by the PROMIS Sleep Disturbance Scale
pre intervention and post intervention (3 weeks)
Total Sleep Time (TST)
pre intervention and post intervention (3 weeks)
Wake After Sleep Onset (WASO)
pre intervention and post intervention (3 weeks)
Sleep Latency
pre intervention and post intervention (3 weeks)
- +2 more secondary outcomes
Study Arms (2)
VR-PMR
EXPERIMENTALPMR
ACTIVE COMPARATORInterventions
The VR-PMR intervention is a self-administered 20-minute session, conducted for 3 consecutive days, one hour before bedtime. PMR, participants will tighten and relax specific muscle groups in sequence from the upper body to the lower body then vice versa. While taking deep breaths inhaling through the nose and exhaling through the mouth, patients will be asked to first tense a muscle tightly and hold for slow count of 5 seconds and then relax quickly and completely for 10 seconds until all the tightness and pain flow out of the muscles. During PMR, participants will be immersed in a relaxing, nature-based VR environment. The VR component will use the Quest 3 Headset. Participants will be immersed in a virtual nature walk with accompanying relaxing music and nature sounds. Participants will be given a choice of three 360 nature walk videos set in forests or a beach. Audio instructions for PMR will play over the video's audio. Participants will use the participant's own smartphone.
Standard progressive muscle relaxation (PMR) therapy delivered via audio-recorded guides. For PMR, participants will tighten and relax specific muscle groups in sequence from the upper body to the lower body then vice versa. While taking deep breaths inhaling the nose and exhaling through the mouth, patients will be asked to first tense a muscle tightly and hold for slow count of 5 seconds and then relax quickly and completely for 10 seconds until all the tightness and pain flow out of the muscles.
Eligibility Criteria
You may qualify if:
- ≥18 years old;
- sustained a burn injury in the last 6 months or longer;
- Score high on at least one of the following: Insomnia severity index (ISI) score of ≥8, Brief Pain Inventory Short Form (BPI-SF) Pain severity score of ≥3, or PROMIS Itch Severity of ≥55;
- own a smartphone or computer with reliable internet connection for online visits and survey completion;
- able to comfortably wear goggles or headsets on face as determined by self-report.
You may not qualify if:
- Cognitive impairment (Mini Mental Status Exam (MMSE) \< 25);
- history of motion sickness, photosensitivity, photoinduced seizures, and claustrophobia as determined by self-report;
- uncorrected visual or hearing impairments as determined by self-report;
- non-English speaker.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sheera Lerman Zohar, PhD
Johns Hopkins University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 10, 2025
First Posted
January 5, 2026
Study Start
February 27, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
March 5, 2026
Record last verified: 2026-03